baber/WOPTO huggingface dataset:
Patent FI-914149-A0 (FI)
Inventor: BAYER THOMAS
IPC: C12N11/08
Filed: 1991-09-03
Abstract: A process for the continuous conversion of cephalosporin derivatives into glutaryl-7-aminocephalosporanic acid derivatives A process for the continuous conversion of cephalosporin derivatives into the corresponding glutaryl-7-aminocephalosporanic acid derivatives in the presence of a catalyst containing D-amino-acid oxidase is described. The product yield can be increased, where appropriate, by addition of hydrogen peroxide.
Patent FI-914174-A0 (FI)
Inventor: EMONDS-ALT XAVIER
IPC: A61K31/341
Filed: 1991-09-04
Abstract: Arylalkylamines of formula: 
<IMAGE>
 in which: 
 
  - Y denotes 
  - either a group Cy-N in which: 
 
  Cy denotes an optionally substituted phenyl, a C3-C7 cycloalkyl, a pyrimidinyl or a pyridyl, 
 
  - or a group 
<IMAGE>
 in which 
 
  Ar denotes an optionally substituted phenyl, a pyridyl or a thienyl, 
  x is zero or one, 
  X denotes especially a hydroxyl, a C1-C4 alkoxy, a C1-C4 acyloxy, a carboxyl, a C1-C4 carbalkoxy, a cyano, a group -N-(X1)2 in which the groups X1 independently denote hydrogen or a C1-C4 alkyl, a group -S-X2 in which X2 denotes hydrogen or a C1-C4 alkyl group, a group 
<IMAGE>
 in which Alk is a C1-C6 alkyl, or else X forms a double bond with the carbon atom to which it is bonded and with the neighbouring carbon atom in the heterocyclic ring, 
 
  - m is 2 or 3, 
  - Ar' denotes an optionally substituted phenyl, a thienyl, a benzothienyl, a naphthyl or an indolyl, 
  - R denotes hydrogen or a C1-C6 alkyl, 
  - T denotes a group chosen from -CO- and -CW-NH-, W being an oxygen or sulphur atom, and 
  - Z denotes either hydrogen or M or OM when T denotes the group -CO-, or M when T denotes the group -CW-NH-, M denotes a C1-C6 alkyl, a phenylalkyl, a pyridylalkyl, a naphthylalkyl, a pyridylthioalkyl, a styryl or an optionally substituted mono-, di- or tricyclic aromatic or heteroaromatic group, 
  or one of its salts with inorganic or organic acids. 
 
<??>Application: antagonists of neurokinin receptors.
Patent FI-923518-A0 (FI)
Inventor: KOBLITZ RUDOLF
IPC: H03J7/04
Filed: 1992-08-04
Abstract: Analog circuit parts in an integrated circuit, for example filters, can be equalized by a control current by equalizing an additional reference circuit part, whose equalization must be verified externally, with this control current. By using a suitably designed horizontal frequency oscillator whose equalization must also be verified, this reference circuit part can be dispensed with even in known TV receivers. Using additional control circuits in the integrated circuit, fine equalization of the various circuit parts can be carried out automatically by adding a small correction control current to each control current. As a result, the control circuits are free from problems related to background noise, interception range and component tolerances. Equalization of analog bipolar or CMOS integrated circuits.
Patent FI-930810-A0 (FI)
Inventor: HAKALA ILPO
IPC: B66C11/18
Filed: 1993-02-24
Abstract: PCT No. PCT/FI94/00069 Sec. 371 Date Dec. 21, 1994 Sec. 102(e) Date Dec. 21, 1994 PCT Filed Feb. 23, 1994 PCT Pub. No. WO94/19273 PCT Pub. Date Sep. 1, 1994A procedure for moving the main girder (3) and trolley (2) of a crane uses a gantry part (6) with its bracing structures and a traversing machinery with traversing ropes (4), the traversing machinery being mounted in conjunction with the gantry part. According to the procedure, the trolley is moved by the same traversing machinery as the main girder. When the main girder (3) is to be moved, the trolley (2) is interlocked so that it remains immovable with respect to the gantry (6) and the traversing movement is performed by winding one of the traversing ropes (4a or 4b) onto the winding drum (1) of the traversing machinery and at the same time unwinding the traversing rope (4b or 4a) on the opposite side from the winding drum (1). When the trolley (2) is to be moved, the trolley interlock is released and the traversing movement is performed in the manner described above.
Patent FI-935730-A0 (FI)
Inventor: THOMAS DENNIS ALBERT
IPC: A44B18/00
Filed: 1993-12-20
Abstract: The invention is a refastenable mechanical fastening system, made of free formed prongs (22) joined to a substrate (24). The prongs (22) taper and are nonperpendicularly oriented relative to the plane of the substrate. The prongs (22) also have an azimuthal angle relative to the machine direction of the substrate. Each prong (22) has an engaging means (30) projecting laterally from the periphery of the prong. The free formed prongs (22) are manufactured by the process of depositing liquid material onto a moving substrate (24) to form the base of the prong, stretching the liquid material in a direction parallel to the plane of the substrate (24), severing the stretched material to form the distal end and engaging means (30) of the prong (22) and allowing the prong to azimuthally angle. The advantageous usage of the fastening system in an article of manufacture, such as disposable absorbent article specifically a diaper, is also disclosed.
Patent FI-943017-A0 (FI)
Inventor: HEDBERG MATS
IPC: H03K5/13
Filed: 1994-06-22
Abstract: Switching elements (38,40,42,44) have auxiliary clock signal inputs to receive clock signals. A selector circuit (46) receives a control signal from a control signal generator (2), and selects one of the switching elements, allowing one of the clock signals onto a common output (18). The control signal has a variable amplitude and polarity. The selector circuit comprises a logic control circuit, analogue switch and analogue selector which continuously tracks the amplitude and polarity of the control signal to select and activate the control output (48,50,52,54) responsible for switching a switching element.
Patent FI-943527-A0 (FI)
Inventor: AFANASENKO NIKOLAI IVANOVICH
IPC: A63B21/055
Filed: 1994-07-27
Abstract: The device for treating patients with disturbances of posture and motor activity comprises holding means (1) for shoulder, pelvis, knee, feet, elbows, hands and fingers which are mutually connected by fixing elements. The fixing elements are designed as resilient tensile elements (2) and arranged on the body surface of the patient in antagonistic pairs according to the principle of the anatomical position of the skeletal muscles. Each tensile element (2) is connected to two holding means (1) and comprises a tension controller (3) for tensioning thereof, which is located between the tensile element (2) and one of the holding means (1) via a clasp (5).
Patent FI-952927-A0 (FI)
Inventor: HAUTOJAERVI JONI
IPC: A61L15/42
Filed: 1995-06-14
Abstract: The present invention relates to a method to treat non-woven sheet or web materials in order to achieve a fluid transfer capacity in one direction of the material different from the fluid transfer capacity in a crossing direction. The method involves a flexographic printing procedure for coating the material zone-wise with wetting or hydrophobizing agents. The printed nonwoven materials contain elongated, continuous hydrophilic stripes with elongated, continuous hydrophobic stripes between the hydrophilic stripes. The hydrophilic stripes transport fluid in the elongated direction, while the hydrophobic stripes prevent fluid transport to the cross direction. The nonwoven materials according to the invention can be used eg. as sublayers or transport layers in disposable, hygienic absorbent articles. <IMAGE>
Patent FI-953138-A0 (FI)
Inventor: LEI XIAO PING
IPC: D06M13/432
Filed: 1995-06-22
Abstract: In the flame-retardant treatment of fabrics, there is provided a means for increased "loading" of phosphorus compounds (up to 25% moisture is retained after impregnation and drying of the fabric). This in turn enables a phosphonium compound "add-on" of 50% to 73% (relative to the weight of the fabric) and gives a correspondingly higher degree of flame-retardant properties.
Patent FI-953379-A0 (FI)
Inventor: KUMMERMEHR HANS
IPC: B32B7/12
Filed: 1995-07-10
Abstract: Laminated mineral wool products which have to comply with high fire protection standards, such as building material belonging to Class A2 according to DIN 4102, require special production expenses if the laminating foil is to be reliably fastened with organic glue without downgrading its fire protection classification. By foaming the glue it is possible to manage with a fraction of the hitherto required quantity of glue without having to accept an essential lowering of glue performance. As a result, organic glue can be used without its fire load having to be neutralised by polluting flame-inhibiting agents. Furthermore the glue foam causes less problems during processing in production, reduces the charged quantity of glue, and reduces the required drying capacities. It is particularly suited for difficult applications such as laminating felt which is rolled for packaging or laminated panels comprising erect fibers.
Patent FI-970803-A0 (FI)
Inventor: COLLINS MARK L
IPC: C12Q1/6832
Filed: 1997-02-26
Abstract: A method for the chemical synthesis of isoguanosine or 2'-modified isoguanosine starting from the corresponding guanosine derivative is provided.
Patent AP-8900132-A0 (AP)
Title: Bordetella pertussis vaccine
Inventor: CAPIAU CARINE
IPC: C07K14/00
Filed: 1989-07-14
Abstract: A vaccine for protection against whooping cough which comprises protein encoded by a b. Pertussis toxin amino acid coding sequence containing an entire or truncated b pertussis toxin s1 subunit amino acid coding sequence which contains a modification of the tryptophan residue at aminio acid position 26.
Patent AU-PR675501-A0 (AU)
Title: A method and device for separating particulate material
IPC: B07B13/08
Filed: 2001-08-01
Abstract: A method of separating particulate material of differing size or density including the steps of: tumbling the particulate material to produce continuous or discrete avalanches ( 19 ) in the surface of the particulate material to move particles of smaller size ( 14 ) or higher density ( 22 ) towards the centre of the particulate material and particles of larger size ( 16 ) or lower density ( 24 ) radially outward from the centre of the particulate material; and extracting particles at selected radial locations ( 8, 10 ). A device for separating particulate material of differing size or density is also provided.
Patent FI-20002086-A0 (FI)
Inventor: SEPPAELAE HANNU
IPC: G01R31/28
Filed: 2000-09-21
Abstract: A testing system for automatic testing of circuit boards (1) in a circuit board manufacturing line. The testing system comprises a set (I) of test modules (4) comprising a testing apparatus. Each test module comprises a horizontal module conveyor (5) for conveying a circuit board (1) into and out of the test module. The test modules are arranged in a superposed relation with respect to each other. The set (I) contains test modules differing from each other so that the testing operations performed by these test modules are different from each other. A feed device (6) has been fitted to receive circuit boards from the first line conveyor (3) and to feed them into the test modules (4).
Patent IL-106576-A0 (IL)
Title: Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
IPC: A61K38/17
Filed: 1993-08-03
Abstract: This invention relates to a method of treatment of patients having lesions resulting from cancer cells and to an application as an anti-cancer composition of undenatured whey protein concentrate.
Patent IL-107229-A0 (IL)
Title: Intermediates for preparing antifolate compounds and processes thereto
IPC: C07D211/78
Filed: 1993-10-11
Abstract: This invention relates to intermediates, and processes thereto, for the preparation of tetrahydropyrido[2,3-d]pyrimidines which are useful for the treatment of susceptable neoplasms.
Patent IL-109465-A0 (IL)
Title: Process for preparing intermediates for the synthesis of antifungal agents
IPC: C07C69/65
Filed: 1994-04-28
Abstract: Disclosed is a process for preparing chiral compounds of the formula (I)    <IMAGE>  (I)  wherein: X1 and X2 are independently F or Cl; and E is -SO2R2, wherein R2 is C1-C6 alkyl, -C6H4CH3 or -CF3; its enantiomer and racemates thereof, useful in the synthesis of tetrahydrofuran azole antifungals. Novel compounds of the formula   <IMAGE>   or   <IMAGE>   wherein: X1 and X2 are independently F or Cl; B represents -C(O)Q* or -CH2OR''; Q* represents a chiral auxiliary group; R'' represents a hydroxy protecting group selected from -CH2C6H5, or -C(O)R1, wherein R1 is C1-C6 alkyl; and A represents Cl, Br, I or triazolyl; are also disclosed.
Patent IL-111357-A0 (IL)
Title: 16-substituted-4-aza-androstanes, their preparation and pharmaceutical compositions containing them
IPC: A61P17/14
Filed: 1994-10-21
Abstract: Compounds of the Formula Iare inhibitors of the 5alpha-reductase 1 isozyme, and are useful alone, or in combination with a 5alpha-reductase 2 inhibitor, for the treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, and benign prostatic hyperplasia.
Patent IL-114246-A0 (IL)
Title: Method for the purification of 23-e isomer of 23-imino derivatives of ll-f28249 compounds
IPC: A01N43/90
Filed: 1995-06-21
Abstract: The present invention provides a method for the purification of a 23-E isomer of a 23-imino derivative of a LL-F28249 compound having the structural formula I <CHEM>
Patent IL-115744-A0 (IL)
Title: Peptides derived from the autoantigen and pharmaceutical compositions containing them
IPC: A61K38/04
Filed: 1995-10-24
Abstract: PCT No. PCT/EP95/04201 Sec. 371 Date Mar. 25, 1996 Sec. 102(e) Date Mar. 25, 1996 PCT Filed Oct. 25, 1995 PCT Pub. No. WO96/13517 PCT Pub. Date May 9, 1996The present invention relates to novel peptides derived from the autoantigen HC gp-39, said peptides comprising at least one of the amino acid sequences FGRSFTLAS (SEQ ID No. 1), FTLASSETG (SEQ ID No. 2), YDDQESVKS (SEQ ID No. 3) and FSKIASNTQ (SEQ ID No. 4). The peptides resemble MHC Class II restricted T-cell epitopes present on the autoantigen HC gp-39 in articular cartilage. HC gp-39 and said peptides can be used in antigen-specific treatment of articular cartilage destruction in autoimmune diseases to induce tolerance of the immune system. The autoantigen HC gp-39 and said peptides are also suitable to induce arthritis in non-human animals, preferably mice. The invention furthermore relates to pharmaceutical compositions comprising said autoantigen and/or said peptides, a diagnostic method for the detection of autoreactive T cells in a test sample and test kits to be used in said method.
Patent IL-129329-A0 (IL)
Title: Chiral ferrocenyls
IPC: B01J31/16
Filed: 1997-10-06
Abstract: PCT No. PCT/EP97/05480 Sec. 371 Date Mar. 8, 1999 Sec. 102(e) Date Mar. 8, 1999 PCT Filed Oct. 6, 1997 PCT Pub. No. WO98/15565 PCT Pub. Date Apr. 16, 1998The invention relates to chiral ferrocenyls of formula (I) wherein Ra is -P(R10R11) or -SR12; Rb is -P(R'10R'11), -SR'12, -CH=NR12, -CH2-NH-R12 or -CH2-O-P(R10R11); and the other substituents are as defined in claim 1, which may be used as ligands for transition metal catalysts in enantioselective reactions.
Patent IL-129718-A0 (IL)
Title: Synthesis of nanotubes of transition metal chalcogenides
IPC: G01Q30/08
Filed: 1999-05-02
Abstract: Nanotubes of transition metal chalcogenides as long as 0.2-20 microns or more, perfect in shape and of high crystallinity, are synthesized from a transition metal material, e.g., the transition metal itself or a substance comprising a transition metal such as an oxide, water vapor and a H<SUB>2</SUB>X gas or H<SUB>2 </SUB>gas and X vapor, wherein X is S, Se or Te, by a two-step or three-step method. The transition metal chalcogenide is preferably WS<SUB>2 </SUB>or WSe<SUB>2</SUB>. Tips for scanning probe microscopy can be prepared from said long transition metal chalcogenide nanotubes.
Patent IL-130127-A0 (IL)
Title: A carton box retainer
IPC: B65D73/00
Filed: 1997-12-05
Abstract: A carton box retainer for a plurality of carton boxes each having opposed ends. The retainer includes a retention member having a plurality of pairs of connection elements spaced along the retention member, each pair of connection elements being connectable to the opposed ends of a carton box for attaching the carton box to the retention member. The connection elements are detachably secured to the carton box and/or the remainder of the retention member in order to enable the carton boxes to be separated from the retainer.
Patent IL-134340-A0 (IL)
Title: Cemented carbide cutting tool insert
IPC: B22F7/00
Filed: 2000-02-02
Abstract: The present invention relates to a coated cemented carbide insert for turning of steel, like low alloyed steels, carbon steels and tough hardened steels at high cutting speeds. The cemented carbide consists of WC, 2-10 wt-% Co and 4-12 wt-% of cubic carbides of metals from groups IVa, Va or VIa of the periodic table, preferably Ti, Ta and Nb. The Co-binder phase is highly alloyed with W with a CW-ratio of 0.75-0.90. The insert has a binder phase enriched and essentially cubic carbide free surface zone A of a thickness of <20  mu m and along a line C, essentially bisecting the edge, in the direction from the edge to the centre of the insert, a binder phase content increases essentially monotonously until it reaches the bulk composition. The binder phase content at the edge in vol-% is 0.65-0.75 times the binder phase content of the bulk and the depth of the binder phase depletion is 100-300  mu m, preferably 150-250  mu m. The insert is coated with 3-12  mu m columnar TiCN-layer followed by a 2-12  mu m thick Al2O3-layer.
Patent IL-138209-A0 (IL)
Title: Passive infrared detector
IPC: G08B29/04
Filed: 2000-09-01
Abstract: A passive infra-red (IR) detector has an entrance window (3) for IR-radiation, an IR-sensor (5) with an evaluation circuit (6) and an anti-masking device, comprising an optical transmitter (8,10) and an optical receiver (9), for detection of processes or optical changes directly in front of the detector and/or changes of the optical properties of the entrance window (3). Two channels (14,15) are provided for evaluation of the anti- masking device signals, one channel (14) being designated PL- channel, and reacting to time-limited processes, and the other (15) is designated as RT-channel, for reacting to time-stabilised processes or changes. The signals of two channels (14,15) are evaluated in together.
Patent IL-144221-A0 (IL)
Title: Method and equipment for pairing or cabling two or more threads when entering textile machines used for knitted goods, hosiery and similar
IPC: D03J1/04
Filed: 2000-02-07
Abstract: An apparatus and method for pairing at least two threads for processing in a textile machine. The apparatus includes individual thread feeding devices for furnishing individual threads to a pairing device in which the individual threads are formed into a single resulting paired thread, and a paired thread feeding device, which includes a cylindrical accumulator coaxial with the individual thread feeder devices, for receiving the single resulting paired thread from the paired feed device and delivering the single resulting paired thread, under controlled tension, to the textile machine.
Patent IL-149989-A0 (IL)
Title: Method for decaying
IPC: C05F17/00
Filed: 2000-12-04
Abstract: The present invention relates to a method for treating organic matter to promote mouldering wherein the organic material is subjected to a splitting process followed by a freeze drying process prior to being transferred for deposition for mouldering.
Patent IL-172185-A0 (IL)
Title: Method of diagnosis lung damage
IPC: G01N33/68
Filed: 2005-11-24
Abstract: The present invention relates generally to a method of diagnosing or predicting the development of lung damage and more particularly, to a method of diagnosing or predicting the development of alveolo-capillary membrane damage. The method of the present invention is useful inter alia for detecting lung damage or predicting the development of lung damage such as that caused by noxious agents or as an undesirable side effect resulting from exposure to a therapeutic agent and for monitoring the progress of lung damage.
Patent IL-178670-A0 (IL)
Title: Multi-channel synthesizer and method for generating a multi-channel output signal
IPC: H04S3/00
Filed: 2006-10-17
Abstract: A multi-channel synthesizer includes a post processor for determining post processed reconstruction parameters or quantities derived from the reconstruction parameter for an actual time portion of the input signal so that the post processed reconstruction parameter or the post processed quantity is different from the corresponding quantized and inversely quantized reconstruction parameter in that the value of the post processed reconstruction parameter or the derived quantity is not bound by the quantization step size. A multi-channel reconstructor uses the post-processed reconstruction parameter for reconstructing the multi-channel output signal. By post processing reconstruction parameters in connection with multi-channel encoding/decoding allows a low data rate on the one hand and a high quality on the other hand, since strong changes in the reconstructed multi-channel output signal because of a large quantization step size for the reconstruction parameter, which is preferable because of low bit rate requirements, are reduced.
Patent RO-127488-A0 (RO)
Title: Film-forming topical preparation with protective, regenerating and wound-healing effects
Inventor: ALEXANDRU VALENTINA
IPC: A61K9/06
Filed: 2011-09-07
Abstract: The invention relates to a film-forming topical preparation with protective, regenerating and wound-healing effects and to a process for preparing the same. According to the invention, the preparation comprises 25...50 g of bees wax, 5...10 g of cetaceum, 2.5...5 g of salve base, 7.3...14.6 g of olive oil, 0.425...0.85 g of zinc oxide, 0.120...0.240 g of lyophilizing phytocomplex of Equisetum arvense, Achillea millefolium, Hyssopus officinalis and Echinacea purpurea, 1...2 g of collagen hydrolysate of an average weight of 100...120000 Da, 0.232...0.262 g of tocopherol , 0.150...0.300 g of neomycin, 0.065...0.125 g of grapefruit seed extract, 0.05...0.1 g of lavender oil, 7.3...14.6 g of purified water. The process claimed by the invention consists, in a first stage, in mixing the aerial parts of dried and mechanically comminuted plants, the mixture being then subjected for 10 days to extraction in 50...70% ethanol, in a plant mixture : solvent ratio of 1:8, after which the resulting solution is filtered and concentrated at temperatures of 40...50°C under vacuum, is lyophilized and results in a phytocomplex as powder to be stored in sealed flasks at a temperature of 4°C, then, in a second stage, there is prepared a composition I consisting of bees wax, salve base and tocopherol whereto there is admixed a composition II consisting of pure water and zinc oxide, after which a composition III consisting of olive oil and neomycin sulphate is admixed thereto and, finally, there is admixed a composition IV consisting of collagen hydrolisate sterilized by filtration wherein the solubilized phytocomplex has been added, the four compositions are mixed together, then lavender oil and a natural preservative are admixed thereto, wherefrom there is obtained a preparation which is stored in containers at a temperature of 4°C.